Is ABCL up or down today?
ABCL is up 2.17% today, last at 5.41. This stock moved +2.17% versus the prior close.
ABCL · ABCL
ABCL (ABCL) is trading at 5.41, up 2.17% on the session. Price action shows weakness or stretched conditions worth watching.
Over the past 7 days, 17 headlines skew mixed. Macro/Market and Earnings themes dominated coverage. Stories with measurable price impact averaged -12.12% — headlines dragged the stock.
Social buzz is mixed — no strong crowd signal.
Analyst firms are mostly reiterating — no strong directional shift lately.
ABCL is up 2.17% today, last at 5.41. This stock moved +2.17% versus the prior close.
Over the past 7 days, 17 headlines skew mixed. Macro/Market and Earnings themes dominated coverage. Stories with measurable price impact averaged -12.12% — headlines dragged the stock. Dominant story: Vertex Pharmaceuticals (VRTX) Expands Its Pipeline Reach, Is The Stock Fully Valued? (1 source, neutral) RSI is 40 — leaning bearish Price below 50-day average — short-term weakness Social (demo): 42% of recent mentions lean bullish — mixed social mood.
Loaded: Jan 2026 – Jul 2026 (124 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Google Trends data is temporarily unavailable — common on cloud hosts. Search interest is optional context only.
Based on 11,552 mentions over 30d
Vertex Pharmaceuticals (VRTX) Expands Its Pipeline Reach, Is The Stock Fully Valued?
ABCL Looks 4.5% Overvalued on GF Value™ - GuruFocus
AbCellera, Vertex Pharma ink drug discovery deal (ABCL:NASDAQ) - Seeking Alpha
AbCellera inks drug discovery deal with Vertex Pharma
ABCL Looks 3.8% Overvalued on GF Value™ - GuruFocus